Guest guest Posted June 23, 2006 Report Share Posted June 23, 2006 Hi Chris, & All, > Thanks for any insights into this formula. Chris See: http://tinyurl.com/qkv5v .... MCA identified examples of ... a product named Xiaoke Wan which included the oral hypoglycaemic agent glibenclamide as a listed ingredient. Glibenclamide is restricted as a POM ingredient. Moreover, a product containing such a non herbal ingredient could not in any case legally be sold as an unlicensed herbal remedy. A 58 year old woman suffered hypoglycaemic coma following the use of such a remedy. Bailey CJ, Brown D, Smith W, Bone AJ. Xiaoke, a traditional Chinese treatment for diabetes. Studies in streptozotocin diabetic mice and spontaneously diabetic BB/E rats. Diabetes Res. 1987 Jan;4(1):15-8. Xiaoke tea is consumed as a traditional herbal treatment for diabetes mellitus in China. An aqueous extract of Xiaoke (1 g of dried plant preparation in 64 ml of water), supplied ad lib in place of drinking water during the induction and development of streptozotocin diabetes in mice, reduced (about 30%) plasma glucose concentrations by 25 days. The polydipsia and hyperphagia of the streptozotocin diabetic mice were also reduced by Xiaoke, and the effects lapsed after treatment was withdrawn. Xiaoke did not significantly alter plasma insulin concentrations. Consumption of the Xiaoke extract by insulin-treated diabetic BB/E Wistar rats did not affect glycaemic control or body wt. When insulin treatment was reduced and discontinued, Xiaoke failed to prevent the progression of severe hyperglycaemia and weight loss. The results suggest that the slowly generated antihyperglycaemic effect of Xiaoke in streptozotocin diabetic mice may involve an extrapancreatic effect on food intake, glucose production or glucose clearance. However, as evidenced in BB/E rats, Xiaoke does not substitute for insulin in the absence of endogenous insulin secretion. PMID: 3552362 [PubMed - indexed for MEDLINE] Hale PJ, Horrocks PM, Wright AD, Fitzgerald MG, Nattrass M, Bailey CJ. Xiaoke tea, a Chinese herbal treatment for diabetes mellitus. Diabet Med. 1989 Nov;6(8):675-6. Diabetic Clinic, General Hospital, Birmingham, UK. Xiaoke tea, a traditional Chinese treatment for diabetes mellitus, lowered blood glucose concentrations in streptozotocin diabetic mice. To investigate Xiaoke clinically, a double-blind crossover study was undertaken in 12 non- insulin-treated diabetic patients. Xiaoke tea and ordinary tea (infusion of 2.72 g, 4 times daily) were consumed in random order for 4 weeks. A standard breakfast meal was taken before and after each treatment period. Xiaoke did not significantly affect glycosylated haemoglobin, basal or post- breakfast serum glucose and insulin concentrations, intermediary metabolite concentrations, triglyceride and cholesterol. No adverse side- effects of Xiaoke were evident. Publication Types: Clinical Trial Randomized Controlled Trial PMID: 2532099 [PubMed - indexed for MEDLINE] Piao CL, Nan HM, Jiang Z, Nan Z. [Effect of combined therapy of xiaoke shen'an capsule and western medicine in diabetic nephropathy] [Article in Chinese] Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Jul;25(7):650-2. Department of Endocrinology, Hospital Affiliated to Changchun College of Traditional , Changchun. Piaochunli981027 OBJECTIVE: To observe the therapeutic effect of xiaoke shen' an capsule on diabetic nephropathy. METHODS: Ninety patients with diabetic nephropathy were randomly divided into two groups, the patients in the control group (CG) were treated with conventional western medicine, and those in the treated group (TG) were treated with combined therapy of xiaoke shen'an capsule and conventional western medicine. The treatment course of both groups was 8 weeks, and the therapeutic effect related indexes were measured before and after treatment. RESULTS: The curative rate was 85.0% and 73.3% in CG and TG respectively, it was better in TG than that in CG (P < 0.05). Indexes such as fasting blood glucose, glycosylated hemoglobin, blood pressure, quantity of 24h urinary protein, urinary albumin excretion rate, renal function, blood lipids and hemoreheologic parameters were significantly different before and after treatment in TG (P < 0.05 or P < 0.01). As compared with CG, some of these indexes after treatment were superior to those in CG (P < 0.01 or P < 0.05). CONCLUSION: Combined therapy of xiaoke shen'an capsule and conventional western medicine has definite therapeutic effect on diabetic nephropathy. Publication Types: Clinical Trial Randomized Controlled Trial PMID: 16089148 [PubMed - indexed for MEDLINE] http://www.tourasia.net/mellitus/xiaoke/ says: Xiaoke Wan for Diabetes: The pill is a drug for diabetes, with actions of nourishing kidney and yin, benefiting vital energy and promoting the production of body fluid. It is indicated for cases with polydipsia, polyuria, potyphagia, emaciation, fatigue, sleeplessness, lumbago, and high glucose level in the blood and urine. This diabetes pill is proved to be highly effective with small dosage and few side effect, and is especially effective for incipient, mild, moderate and stable cases of diabetes mellitus in which the pancreas is still partially functioning. Since the quality of this diabetes pill is stable and its effectiveness is definite,this preparation was awarded " Famous Trade Brand Product " by Guangdong Province in 1996. Trade Mark: Zhong Yi Brand Diabetes Medicine Description: Black concentrate pills; taste, sweet, sour , slightly astringent. , Ingredients: Radix Astragali, Radix Rehmanniae and Radix Trichosanthis,Glibenclamide (2.5mg per 10 pills). Dosage: 1. 25 - 2.5g (about 5 - 10 diabetes pills) for oral use with boiled water after meal, thrice daily. See also: http://www.i-c-m.org.uk/Journal/2003/oct03/009.htm and www.moh.govt.nz/moh.nsf/by+unid/0DE600666A1711A8CC256CCF0064D 574?Open http://www.cantonbrand.com/en/product/viewProduct.asp?productid=116 says: Product Name: XIAOKE PILLS REFERENCE Category: Chinese Patent Medicines Company: GuangZhou ZhongYi Pharmaceutical Co.Ltd Introduction INGREDIENTS£º Radix Puerariae, Radix Rehmanniae, Radix Astragali, Radix Trichosanthis, Stylus Zeae Maydis, Fructus Schisandrae Sphenantherae, Rhizoma Dioscoreae and Glibenclamide. DESCRIPTION: Black coated concentrated pills; sweet, sour and slightly astringent in taste. ACTIONS AND INDICATIONS: Nourish kidney-yin, benefit qi, promote generation of body fluid. Indicated for diabetes mellitus due to deficiency of qi and yin (non-insulin dependent diabetes) manifested as thirst, polydipsia, polyphagia, polyuria, polyorexia, emaciation, tiredness, fatigue, shortness of breath, indolent about speaking. USAGE AND DOSAGE: For oral use, 5-10 pills after meal, 2-3 times daily. According to the state of illness, increased of 5 pills once progressively but not exceeded 30 pills daily, when increased of 20 pills daily, at least divided into 2 times for oral use. During a satisfactory result is obtained, reduced the dosage to a maintenance dose and directed by physician. CONTRAINDICATIONS: 1. Forbidden to use sulfonylurea (antidiabetic) during applied this preparation, in case combined use with other antidibetics simultaneously, the patients should be directed by physician. 2. Forbidden for pregnant women foster-nurse, insulin dependence, and those are unsuitable for glibenclamide. 3. Forbidden for cases with allergic reaction of sulfonamides. 4. Forbidden for cases complicated with ketoacidosis, coma, severe burn, infection, severe traumatic injury and great operation. 5. Forbidden for cases with hepatic or renal insufficiency. 6. Forbidden for cases with leukopenia, agranulocytosis or thrombocytopenia. 7. Forbidden drinking. Best regards, Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 23, 2006 Report Share Posted June 23, 2006 I appreciate your replying to my question. I had a client come to me with the question saying it was the only thing that help his blood sugar, but he couldn't find it any more. Thanks again, Chris In a message dated 6/22/2006 10:19:35 PM Eastern Standard Time, writes: Hi Chris, & All, > Thanks for any insights into this formula. Chris See: http://tinyurl.com/qkv5v .... MCA identified examples of ... a product named Xiaoke Wan which included the oral hypoglycaemic agent glibenclamide as a listed ingredient. Glibenclamide is restricted as a POM ingredient. Moreover, a product containing such a non herbal ingredient could not in any case legally be sold as an unlicensed herbal remedy. A 58 year old woman suffered hypoglycaemic coma following the use of such a remedy. Bailey CJ, Brown D, Smith W, Bone AJ. Xiaoke, a traditional Chinese treatment for diabetes. Studies in streptozotocin diabetic mice and spontaneously diabetic BB/E rats. Diabetes Res. 1987 Jan;4(1):15-8. Xiaoke tea is consumed as a traditional herbal treatment for diabetes mellitus in China. An aqueous extract of Xiaoke (1 g of dried plant preparation in 64 ml of water), supplied ad lib in place of drinking water during the induction and development of streptozotocin diabetes in mice, reduced (about 30%) plasma glucose concentrations by 25 days. The polydipsia and hyperphagia of the streptozotocin diabetic mice were also reduced by Xiaoke, and the effects lapsed after treatment was withdrawn. Xiaoke did not significantly alter plasma insulin concentrations. Consumption of the Xiaoke extract by insulin-treated diabetic BB/E Wistar rats did not affect glycaemic control or body wt. When insulin treatment was reduced and discontinued, Xiaoke failed to prevent the progression of severe hyperglycaemia and weight loss. The results suggest that the slowly generated antihyperglycaemic effect of Xiaoke in streptozotocin diabetic mice may involve an extrapancreatic effect on food intake, glucose production or glucose clearance. However, as evidenced in BB/E rats, Xiaoke does not substitute for insulin in the absence of endogenous insulin secretion. PMID: 3552362 [PubMed - indexed for MEDLINE] Hale PJ, Horrocks PM, Wright AD, Fitzgerald MG, Nattrass M, Bailey CJ. Xiaoke tea, a Chinese herbal treatment for diabetes mellitus. Diabet Med. 1989 Nov;6(8):675-6. Diabetic Clinic, General Hospital, Birmingham, UK. Xiaoke tea, a traditional Chinese treatment for diabetes mellitus, lowered blood glucose concentrations in streptozotocin diabetic mice. To investigate Xiaoke clinically, a double-blind crossover study was undertaken in 12 non- insulin-treated diabetic patients. Xiaoke tea and ordinary tea (infusion of 2.72 g, 4 times daily) were consumed in random order for 4 weeks. A standard breakfast meal was taken before and after each treatment period. Xiaoke did not significantly affect glycosylated haemoglobin, basal or post- breakfast serum glucose and insulin concentrations, intermediary metabolite concentrations, triglyceride and cholesterol. No adverse side- effects of Xiaoke were evident. Publication Types: Clinical Trial Randomized Controlled Trial PMID: 2532099 [PubMed - indexed for MEDLINE] Piao CL, Nan HM, Jiang Z, Nan Z. [Effect of combined therapy of xiaoke shen'an capsule and western medicine in diabetic nephropathy] [Article in Chinese] Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Jul;25(7):650-2. Department of Endocrinology, Hospital Affiliated to Changchun College of Traditional , Changchun. Piaochunli981027 OBJECTIVE: To observe the therapeutic effect of xiaoke shen' an capsule on diabetic nephropathy. METHODS: Ninety patients with diabetic nephropathy were randomly divided into two groups, the patients in the control group (CG) were treated with conventional western medicine, and those in the treated group (TG) were treated with combined therapy of xiaoke shen'an capsule and conventional western medicine. The treatment course of both groups was 8 weeks, and the therapeutic effect related indexes were measured before and after treatment. RESULTS: The curative rate was 85.0% and 73.3% in CG and TG respectively, it was better in TG than that in CG (P < 0.05). Indexes such as fasting blood glucose, glycosylated hemoglobin, blood pressure, quantity of 24h urinary protein, urinary albumin excretion rate, renal function, blood lipids and hemoreheologic parameters were significantly different before and after treatment in TG (P < 0.05 or P < 0.01). As compared with CG, some of these indexes after treatment were superior to those in CG (P < 0.01 or P < 0.05). CONCLUSION: Combined therapy of xiaoke shen'an capsule and conventional western medicine has definite therapeutic effect on diabetic nephropathy. Publication Types: Clinical Trial Randomized Controlled Trial PMID: 16089148 [PubMed - indexed for MEDLINE] http://www.tourasia.net/mellitus/xiaoke/ says: Xiaoke Wan for Diabetes: The pill is a drug for diabetes, with actions of nourishing kidney and yin, benefiting vital energy and promoting the production of body fluid. It is indicated for cases with polydipsia, polyuria, potyphagia, emaciation, fatigue, sleeplessness, lumbago, and high glucose level in the blood and urine. This diabetes pill is proved to be highly effective with small dosage and few side effect, and is especially effective for incipient, mild, moderate and stable cases of diabetes mellitus in which the pancreas is still partially functioning. Since the quality of this diabetes pill is stable and its effectiveness is definite,this preparation was awarded " Famous Trade Brand Product " by Guangdong Province in 1996. Trade Mark: Zhong Yi Brand Diabetes Medicine Description: Black concentrate pills; taste, sweet, sour , slightly astringent. , Ingredients: Radix Astragali, Radix Rehmanniae and Radix Trichosanthis,Glibenclamide (2.5mg per 10 pills). Dosage: 1. 25 - 2.5g (about 5 - 10 diabetes pills) for oral use with boiled water after meal, thrice daily. See also: http://www.i-c-m.org.uk/Journal/2003/oct03/009.htm and www.moh.govt.nz/moh.nsf/by+unid/0DE600666A1711A8CC256CCF0064D 574?Open http://www.cantonbrand.com/en/product/viewProduct.asp?productid=116 says: Product Name: XIAOKE PILLS REFERENCE Category: Chinese Patent Medicines Company: GuangZhou ZhongYi Pharmaceutical Co.Ltd Introduction INGREDIENTS£º Radix Puerariae, Radix Rehmanniae, Radix Astragali, Radix Trichosanthis, Stylus Zeae Maydis, Fructus Schisandrae Sphenantherae, Rhizoma Dioscoreae and Glibenclamide. DESCRIPTION: Black coated concentrated pills; sweet, sour and slightly astringent in taste. ACTIONS AND INDICATIONS: Nourish kidney-yin, benefit qi, promote generation of body fluid. Indicated for diabetes mellitus due to deficiency of qi and yin (non-insulin dependent diabetes) manifested as thirst, polydipsia, polyphagia, polyuria, polyorexia, emaciation, tiredness, fatigue, shortness of breath, indolent about speaking. USAGE AND DOSAGE: For oral use, 5-10 pills after meal, 2-3 times daily. According to the state of illness, increased of 5 pills once progressively but not exceeded 30 pills daily, when increased of 20 pills daily, at least divided into 2 times for oral use. During a satisfactory result is obtained, reduced the dosage to a maintenance dose and directed by physician. CONTRAINDICATIONS: 1. Forbidden to use sulfonylurea (antidiabetic) during applied this preparation, in case combined use with other antidibetics simultaneously, the patients should be directed by physician. 2. Forbidden for pregnant women foster-nurse, insulin dependence, and those are unsuitable for glibenclamide. 3. Forbidden for cases with allergic reaction of sulfonamides. 4. Forbidden for cases complicated with ketoacidosis, coma, severe burn, infection, severe traumatic injury and great operation. 5. Forbidden for cases with hepatic or renal insufficiency. 6. Forbidden for cases with leukopenia, agranulocytosis or thrombocytopenia. 7. Forbidden drinking. Best regards, [Non-text portions of this message have been removed] Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.